Widespread prostate specific antigen (PSA) screening underscores the need to identify causes and potential biomarkers of clinically more aggressive prostate cancer. Laboratory and clinical studies suggest that growth factors play an important role in prostate cancer proliferation, apoptosis and angiogenesis. These growth factors include insulin-like growth factor-I (IGF-I) and vascular endothelial growth factor (VEGF). In the Physicians Health Study (PHS), we recently showed that prediagnostic levels of circulating IGF-I were significantly associated with prostate cancer risk, while high levels of IGF binding protein, IGFBP-3, were associated with lower risk. Furthermore, our pilot study data suggests that plasma VEGF levels are significantly higher among patients with metastatic disease compared to patients with localized prostate cancer, and that plasma VEGF levels in advanced prostate cancer patients are prognostic for survival. To understand the underlying nature of these associations, we now propose to extend our previous work on IGF-I and IGFBP-3 to examine the associations of free IGF-I, IGFBP-I, a newly identified polymorphism of IGFBP-3, and circulating levels of VEGF in relation to risk of total and aggressive prostate cancer. We plan to obtain prostate cancer tissue samples from 828 cases to establish biologic links between these epidemiologic findings and phenotypic features of prostate cancer. We will assess the associations of these growth factors with tissue markers for disease progression, including IGF-I downstream signaling (HIF-1 and PTEN), markers of cellular proliferation rate (Ki67), apoptosis (TUNEL), and angiogenesis (VEGF expression and microvascular density). We will also examine the relation of these plasma and tissue markers with prostate cancer relapse and mortality. In the PHS, we have already assembled an extensive prospective clinical and serological database on prostate cancer with almost two decades of follow-up and 1336 prostate cancers. With this proposed study, we will expand upon our epidemiological findings and examine the biology underlying these intriguing results.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA090598-02
Application #
6621505
Study Section
Special Emphasis Panel (ZRG1-SNEM-3 (02))
Program Officer
Patel, Appasaheb1 R
Project Start
2002-02-01
Project End
2007-01-31
Budget Start
2003-02-01
Budget End
2004-01-31
Support Year
2
Fiscal Year
2003
Total Cost
$669,810
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
030811269
City
Boston
State
MA
Country
United States
Zip Code
02115
Yang, Meng; Sesso, Howard D; Colditz, Graham A et al. (2016) Effect Modification by Time Since Blood Draw on the Association Between Circulating Fatty Acids and Prostate Cancer Risk. J Natl Cancer Inst 108:
Yang, Meng; Ayuningtyas, Azalea; Kenfield, Stacey A et al. (2016) Blood fatty acid patterns are associated with prostate cancer risk in a prospective nested case-control study. Cancer Causes Control 27:1153-61
Van Blarigan, Erin L; Kenfield, Stacey A; Yang, Meng et al. (2015) Fat intake after prostate cancer diagnosis and mortality in the Physicians' Health Study. Cancer Causes Control 26:1117-26
Yang, Meng; Kenfield, Stacey A; Van Blarigan, Erin L et al. (2015) Dairy intake after prostate cancer diagnosis in relation to disease-specific and total mortality. Int J Cancer 137:2462-9
Yang, Meng; Kenfield, Stacey A; Van Blarigan, Erin L et al. (2015) Dietary patterns after prostate cancer diagnosis in relation to disease-specific and total mortality. Cancer Prev Res (Phila) 8:545-51
Crowe, Francesca L; Appleby, Paul N; Travis, Ruth C et al. (2014) Circulating fatty acids and prostate cancer risk: individual participant meta-analysis of prospective studies. J Natl Cancer Inst 106:
Chavarro, Jorge E; Kenfield, Stacey A; Stampfer, Meir J et al. (2013) Blood levels of saturated and monounsaturated fatty acids as markers of de novo lipogenesis and risk of prostate cancer. Am J Epidemiol 178:1246-55
Barry, Marc; Dhillon, Preet K; Stampfer, Meir J et al. (2012) ?-Methylacyl-CoA racemase expression and lethal prostate cancer in the Physicians' Health Study and Health Professionals Follow-up Study. Prostate 72:301-6
Shui, Irene M; Stark, Jennifer R; Penney, Kathryn L et al. (2012) Genetic variation in the toll-like receptor 4 and prostate cancer incidence and mortality. Prostate 72:209-16
Kasperzyk, Julie L; Shappley 3rd, William V; Kenfield, Stacey A et al. (2011) Watchful waiting and quality of life among prostate cancer survivors in the Physicians' Health Study. J Urol 186:1862-7

Showing the most recent 10 out of 43 publications